Application of artificial neural networks in prediction of diclofenac sodium release from drug-modified zeolites physical mixtures and antiedematous activity assessment

Journal of Pharmaceutical Sciences

Volumn 103, Issue 4, 2014, Pages 1085-1094

  Krajišnik, Danina ^a   Stepanović Petrović, Radica ^a   Tomić, Maja ^a   Micov, Ana ^a   Ibrić, Svetlana ^a   Milić, Jela ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

adsorption; antiedematous activity; cationic surfactant; clinoptilolite; diclofenac sodium; dissolution; dose response; excipient; in silico modeling; neural networks

Indexed keywords

CARRAGEENAN; CATIONIC SURFACTANT; DICLOFENAC; EXCIPIENT; ZEOLITE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; DRUG RELEASE; DRUG SAFETY; MALE; MOUSE; NONHUMAN; PAW EDEMA; PERCEPTRON; RAT;

ADSORPTION; ANTIEDEMATOUS ACTIVITY; CATIONIC SURFACTANT; CLINOPTILOLITE; DICLOFENAC SODIUM; DISSOLUTION; DOSE-RESPONSE; EXCIPIENT; IN SILICO MODELING; NEURAL NETWORKS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG CARRIERS; EDEMA; MALE; MICE; MODELS, CHEMICAL; NEURAL NETWORKS (COMPUTER); RATS; RATS, WISTAR; SURFACE-ACTIVE AGENTS; ZEOLITES;

EID: 84896393153     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23869     Document Type: Article

References (42)

1. Carretero MI, Pozo M,. 2009. Clay and non-clay minerals in the pharmaceutical industry. Part I. Excipients and medical applications. Appl Clay Sci 46: 73-80.
2. Cerri G, De Gennaro M, Bonferoni MC, Caramella C,. 2004. Zeolites in biomedical application: Zn-exchanged clinoptilolite-rich rock as active carrier for antibiotics in anti-acne topical therapy. Appl Clay Sci 27: 141-150.
3. Rowe RC, Sheskey PJ, Owen SC, Eds. 2006. Handbook of pharmaceutical excipients, 5th ed. London & Washington: Pharmaceutical Press and American Pharmacists Association.
4. Carretero MI, Pozo M,. 2010. Clay and non-clay minerals in the pharmaceutical and cosmetic industries. Part II. Active ingredients. Appl Clay Sci 47: 171-181.
5. Colella C., 2011. A critical reconsideration of biomedical and veterinary applications of natural zeolites. Clay Miner 46: 295-309.
6. Sharma R, Ed. 1999. Surfactant adsorption and surface solubilization. Washington DC: American Chemical Society.
7. Rivera A, Farías T, Ruiz-Salvador AR, de Menorval LC,. 2003. Preliminary characterization of drug support systems based on natural clinoptilolite. Micropor Mesopor Mater 61: 249-259.
8. Rivera A, Farías T,. 2005. Clinoptilolite-surfactant composites as drug support: A new potential application. Micropor Mesopor Mater 80: 337-346.
9. Farías T, de Ménorval LC, Zajacb J, Rivera A,. 2010. Adsolubilization of drugs onto natural clinoptilolite modified by adsorption of cationic surfactants. Colloid Surf B 76: 421-426.
10. Krajišnik D, Milojević M, Malenović A, Daković A, Ibrić S, Savić S, Dondur V, Matijaš ević S, Radulović A, Daniels R, Milić J,. 2010. Cationic surfactants-modified natural zeolites: Improvement of the excipient functionality. Drug Dev Ind Pharm 36 (10): 1215-1224.
11. Farías T, de Ménorval LC, Zajac J, Rivera A,. 2011. Benzalkonium chloride and sulfamethoxazole adsorption onto natural clinoptilolite: Effect of time, ionic strength, pH and temperature. J Colloid Interface Sci 363: 465-475.
12. Krajišnik D, Daković A, Kragović M, Malenović A, Milojević M, Dondur V, Ristić S, Milić J,. 2010. Proceedings of the 8th international conference of the occurrence, properties, and utilization of natural zeolites. Sofia, Bulgaria: Book of Abstracts, pp 151-152.
13. Krajišnik D, Daković A, Malenović A, Milojević-Rakić M, Dondur V, Radulović Ž, Milić J,. 2013. Investigation of adsorption and release of diclofenac sodium by modified zeolites composites. Appl Clay Sci 83-84: 322-326.
14. Galeazzi M, Marcolongo R,. 1993. A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases. Drugs Exp Clin Res 19 (3): 107-115.
15. McNeely W, Goa KL,. 1999. Diclofenac-potassium in migraine: A review. Drugs 57 (6): 991-1003.
16. Sweetman SC, ed. 2009. Martindale: The complete drug reference, 36th ed. London: Pharmaceutical Press.
17. Ding X, Alani AWG, Robinson JR,. 2006. Extended-release and targeted drug delivery systems. In Remington: The science and practice of pharmacy;, Troy DB, Beringer P, Eds. 21st ed., Philadelphia: Lippincott Williams & Wilkins, pp 939-964.
18. Rajabi-Siahboomi AR, Rane MS, Felton LA,. 2012. Oral modified-release drug delivery systems. In Remington: The science and practice of pharmacy;, Allen Jr LV,., Adejare A, Desselle SP, Felton LA, Eds. 22nd ed. London: Pharmaceutical Press, pp 989-998.
19. Hussain AS, Yu XQ, Johnson RD, 1991. Application of neural computing in pharmaceutical product development. Pharm Res 8: 1248-1252.
20. Gupta MM, Jin L, Homma N,. 2005. Learning and adaptation in dynamic neural networks, in static and dynamic neural networks: From fundamentals to advanced theory. Hoboken, New Jersey: John Wiley & Sons, Inc.
21. Samarasinghe S,. 2006. Neural networks for applied sciences and engineering. New York: Aurebach Publications.
22. Djekić Lj, Ibrić S, Primorac M,. 2011. Application of artificial neural networks (ANNs) in development of pharmaceutical microemulsions. In Focus on artificial neural networks;, Flores JA, Ed. New York: Nova Science Publishers, Inc., pp 1-28.
23. Daković A, Tomašević-Čanović M, Rottinghaus GE, Matijašević S, Sekulić Ž,. 2007. Fumonisin B1 adsorption to octadecyldimethylbenzyl ammonium-modified clinoptilolite-rich zeolitic tuff. Micropor Mesopor Mater 105: 285-290.
24. Daković A, Matijašević S, Rottinghaus GE, Dondur V, Pietrass T, Clewett FM,. 2007. Adsorption of zearalenone by organomodified natural zeolitic tuff. J Colloid Interface Sci 311: 8-13.
25. Krajišnik D, Daković A, Milojević M, Malenović A, Kragović M, Bajuk-Bogdanović D, Dondur V, Milić J,. 2011. Properties of diclofenac sodium sorption onto natural zeolite modified with cetylpyridinium chloride. Colloid Surf B 83: 165-172.
26. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington DC: National Academies Press (US).
27. Center for Drug Evaluation and Research (CDER). 2005. Guidance for industry: Nonclinical studies for development of pharmaceutical excipients. FDA CDER. Rockville.
28. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F,. 1995. Carbamazepine exerts anti-inflammatory effects in the rat. Eur J Pharmacol 294: 71-74.
29. Stepanović-Petrović RM, Micov AM, Tomić MA, Ugrešić ND,. 2012. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model. Anesth Analg 115 (6): 1457-1466.
30. Tallarida RJ, Murray RB,. 1986. Manual of pharmacologic calculations with computer programs, 2nd ed. New York, Berlin, Heidelberg, London, Paris, Tokyo: Springer Verlag.
31. Yaksh TL, Noueihed RY, Durant PA,. 1986. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat. Anesthesiology 64: 54-66.
32. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić ND, Prostran MS, Boš ković B,. 2010. Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents. Anesth Analg 110: 1198-1205.
33. Dawson-Saunders B, Trapp RG,. 1994. Basic & clinical biostatistics, 2nd ed. Norwalk: Appleton & Lange.
34. Zupančič Bozič D, Vrečer F, Kozjek F,. 1997. Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network. Eur J Pharm Sci 5: 163-169.
35. Ivic B, Ibric S, Betz G, Djuric Z,. 2010. Optimization of drug release form compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN). Arch Pharm Res 33: 103-113.
36. Petrović J, Ibrić S, Betz G, Parojčić J, D strok signurić Z,. 2009. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets. Eur J Pharm Sci 38: 172-180.
37. Petrović J, Ibrić S, Betz G, D strok signurić Z,. 2012. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees. Int J Pharm 428: 57-67.
38. Adamis Z, Tátrai E, Honma K, Six E, Ungváry G,. 2000. In vitro and in vivo tests for determination of the pathogenicity of quartz, diatomaceous earth, mordenite and clinoptilolite. Ann Occup Hyg 44: 67-74.
39. Pavelić K, Hadžija M, Bedrica L, Pavelić J, Dikić I, Katić M, Kralj M, Bosnar MH, Kapitanović S, Poljak-Blaži M, Križanac S, Stojković R, Jurin M, Subotić B, Čolić M,. 2001. Natural zeolite clinoptilolite: New adjuvant in anticancer therapy. J Mol Med 78: 708-720.
40. Pavelić K, Hadžija M,. 2003. Biomedical application of zeolites. In Handbook of zeolite science and technology;, Auerbach SM, Carrado KA, Dutta PK, Eds. New York: Marcel Dekker, pp 1143-1174.
41. Odabasoglu F, Halici Z, Aygun H, Halici M, Atalay F, Cakir A, Cadirci E, Bayir Y, Suleyman H,. 2011. α-Lipoic acid has anti-inflammatory and anti-oxidative properties: An experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations. Br J Nutr 105 (1): 31-43.
42. Sehgal R, Kumar VL,. 2005. Calotropis procera latex-induced inflammatory hyperalgesia-effect of antiinflammatory drugs. Mediat Inflamm 31: 216-220.